Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 1,793,400 | 1,724,300 | 1,627,837 | 1,538,271 | 1,524,485 |
| Cost of Goods | 228,000 | 192,300 | 203,101 | 186,182 | 184,520 |
| Gross Profit | 1,565,400 | 1,532,000 | 1,424,737 | 1,352,089 | 1,339,965 |
| Operating Expenses | 1,603,300 | 644,500 | 679,035 | 680,030 | 622,452 |
| Operating Income | -37,900 | 887,800 | 745,802 | 672,241 | 718,033 |
| Interest Expense | 15,500 | 15,700 | 16,337 | 13,856 | 13,871 |
| Other Income | 9,200 | -51,200 | 159,260 | 87,486 | 120,608 |
| Pre-tax Income | -44,200 | 820,900 | 888,725 | 745,871 | 824,770 |
| Income Tax | -111,200 | 167,800 | 284,482 | 78,437 | -12,500 |
| Net Income Continuous | 67,000 | 653,100 | 604,243 | 667,434 | 837,270 |
| Net Income | $67,000 | $653,100 | $604,243 | $667,434 | $837,270 |
| EPS Basic Total Ops | 0.26 | 2.52 | 2.34 | 2.56 | 3.22 |
| EPS Basic Continuous Ops | 0.26 | 2.52 | 2.33 | 2.56 | 3.22 |
| EPS Diluted Total Ops | 0.26 | 2.49 | 2.29 | 2.53 | 3.18 |
| EPS Diluted Continuous Ops | 0.26 | 2.49 | 2.30 | 2.53 | 3.18 |
| EBITDA(a) | $-6,600 | $916,600 | $775,142 | $698,883 | $744,730 |